Given the reality that the television industry is changing rapidly as new methods of content management and delivery become increasing viable, Intel (NASDAQ: INTC ) does not want to be shut out. Particularly as the PC market continues to contract, Chipzilla is in need of a new growth area upon which to capitalize. A concerted effort to change the way we watch TV�is not a bad place to start. To this end, Intel has promised to release its new Internet-based live TV product by the end of the year.
What is Intel TV?
The new service from Intel -- which is expected to be called OnCue�-- is an attempt by the chip maker to deliver a full complement of live TV, on-demand content, and other options to consumers�over a broadband Internet connection. Unlike other set-top boxes like Apple�TV, OnCue would not require a monthly subscription to any of the major cable or satellite providers like Comcast� (NASDAQ: CMCSA ) or Time Warner (NYSE: TWX ) . The service would represent a major shift in the industry, and existing providers are fighting back.
Top 5 Quality Companies For 2015: Rosetta Resources Inc.(ROSE)
Rosetta Resources Inc., an independent exploration and production company, engages in the acquisition, exploration, development, and production of onshore oil and gas resources in the United States. It owns producing and non-producing oil and gas properties located primarily in South Texas, including the Eagle Ford, and in the Southern Alberta Basin in Northwest Montana. As of December 31, 2011, the company had an estimated 965 billion cubic feet equivalent of proved reserves, including 36,370 million barrels of oil, 50,219 million barrels of natural gas liquids, and 446 billion cubic feet of natural gas, as well as drilled 53 net wells. Rosetta Resources Inc. was incorporated in 2005 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Monica Wolfe]
Rosetta Resources (ROSE)
FPA Capital's largest holding is in Rosetta Resources. Here the guru holds on to a total of 1,419,402 shares of the company�� stock which makes up for 9.7% of its total portfolio and 2.32% of the company�� shares outstanding.
- [By Value Digger]
It is clear that these key metrics match the metrics of a heavily natural gas weighted company that also carries significant debt. To prove this, let's check out Comstock Resources (CRK). Comstock sold some assets recently to Rosetta Resources (ROSE) to reduce its long term debt which still remains high though.
Top 10 Healthcare Equipment Companies To Watch In Right Now: (NWBO)
Northwest Biotherapeutics, Inc., a development stage biotechnology company, engages in the discovery, development, and commercialization of immunotherapy products that generate and enhance immune system responses to treat cancer in the United States. Its technology platforms comprise dendritic cell-based cancer vaccines (DCVax) and monoclonal antibodies for cancer therapeutics. The company?s product candidates include DCVax-Prostate for the treatment of non-metastatic hormone independent prostate cancer, which cleared Phase III clinical trial; DCVax-Brain that is in Phase II clinical trial for the treatment of glioblastoma multiforme; and DCVax-LB, which cleared Phase I clinical trial for the treatment of non-small cell lung cancer. Its product candidates also comprise DCVax-Direct that cleared Phase I clinical trial for the treatment of ovarian, head, and neck cancer; and DCVax-L, which completed Phase I/II clinical trials for the treatment of resectable solid tumors. In addition, the company develops CXCR4 antibodies, which are involved in various phases of disease progression, including proliferation of the primary tumor, migration of cancer cells out of the primary tumor, and establishment of distant metastatic sites for the treatment of non-small cell lung cancer, breast cancer, glioblastoma multiforme, colon cancer, melanoma, prostate, pancreatic, kidney, ovarian, and certain blood cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
Advisors' Opinion:- [By Smith On Stocks]
Using my assumptions, the common of Agenus might be worth about $7.00 per share in early 2014 based on the royalties from the Glaxo vaccines and the net operating loss carry forward even if every other asset in the company were valued at zero. However, there may be substantial value in Agenus' internal vaccine programs in recurrent and newly diagnosed glioblastoma and the genital herpes vaccine. Based on a comparison to peer companies like Northwest Biotherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), I believe that the internal programs at Agenus currently may be worth $150 million or $4.45 per share. Adding this to the value of the MAGE A-3 vaccine could produce a stock price of $11.00 in early 2014.
Top 10 Healthcare Equipment Companies To Watch In Right Now: Illumina Inc.(ILMN)
Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include HiSeq 2000, an instrument for high-throughput (up to 200 Gb per run and up to 25 GB per day) sequencing using sequencing-by-synthesis (SBS) technology; Genome Analyzer IIx, an instrument for medium to high-throughput (up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer IIe, an instrument for low to medium throughput (up to 40 Gb per run) sequencing using SBS technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The company?s consumables consist of InfiniumHD Whole-Genome BeadChips comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, which are multi-sample DNA analysis microarrays; iSelect Custom Genotyping BeadChips that are custome r designable SNP genotyping arrays; GoldenGate Assay Method, a high throughput assay and genotyping system; GoldenGate Universal-32 Sample BeadChip, which are 32 sample GoldenGate genotyping arrays; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200?500 kb insert paired-end reads; VeraCode GoldenGate that are low plex GoldenGate genotyping arrays compatible with the BeadXpress System; Standard Sequencing Kit, reagents used for SBS chemistry on sequencing platforms; and Infinium Assay Kit, reagents used to perform Infinium assays on the iScan platform. It also provides sequencing and genotyping services. The company?s customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as research centers. It sells its products through distributors in North America, Europe, the Asia-Pacific, the Middle East, and South Africa. Illumina was founded in 1998 and is headquartered in San Dieg o, California.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of genetic testing specialist Illumina (NASDAQ: ILMN ) popped 12% today after the company's quarterly results and outlook topped Wall Street expectations.�
- [By Monica Gerson]
Illumina (NASDQ: ILMN) is estimated to report its Q3 earnings at $0.40 per share on revenue of $343.56 million.
Texas Instruments (NASDAQ: TXN) is expected to report its Q3 earnings at $0.53 per share on revenue of $3.23 billion.
- [By Anders Bylund]
Back in 2003, Illumina (NASDAQ: ILMN ) was a micro-cap specialist in genetic testing with negative earnings and more debt than cash. The company almost went under while waiting for the genetic-testing market to mature. Now it's a hot name in a red-hot health-care market. Long-term shareholders have pocketed an outsized 4,600% return in 10 years, while the Dow Jones Industrial Average (DJINDICES: ^DJI ) gained just 65%.
Top 10 Healthcare Equipment Companies To Watch In Right Now: Selectica Inc.(SLTC)
Selectica, Inc. provides contract management and sales configuration software solutions that allow enterprises to manage sell-side business processes. It offers Selectica contract lifecycle management (CLM) solution, a contract authoring, analysis, repository, and process automation product that is offered on-premise or hosted basis enables customers to create, manage, and analyze contracts in a single repository. The company also offers Selectica sales configuration (SCS) solution, which consolidates configuration, pricing, and quoting functions into a single application platform. It provides SCS solutions to manufacturers, service providers, and financial services companies to streamline the opportunity-to-order process. In addition, the company provides professional implementation and customization services; on-demand hosting services for CLM solutions; and complex product configuration modeling services for SCS solutions. It sells its CLM products primarily through its direct sales force and strategic and OEM partners, as well as SCS products primarily through partnership relationships in the United States, Canada, India, New Zealand, Switzerland, and the United Kingdom. The company was founded in 1996 and is headquartered in San Jose, California.
Advisors' Opinion:- [By The GeoTeam]
Our recent 2013 articles on SaaS companies Selectica (SLTC), E2open (EOPN), Responsys (MKTG), Vocus (VOCS), and ExactTarget (ET) highlighted such opportunities. The average return since the inception of our coverage currently stands at around 34% (55% at their highs).
Top 10 Healthcare Equipment Companies To Watch In Right Now: Charles River Laboratories International Inc. (CRL)
Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. The company offers a portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Its portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing customized approaches to support both single-study or broad-based programs. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Advisors' Opinion:- [By Damian Illia]
Based in Valencia, Calif., and founded in 1991, MannKind Corporation (MNKD) is a development stage biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapeutic products for diseases like diabetes. The company's lead and only late stage pipeline candidate for this year is Afrezza, an inhalation powder which is an ultra insulin therapy for the treatment of adults with type 1 or type 2 diabetes to control their hyperglycemia. Currently, it is in late-stage clinical trials and a final decision from the U.S. regulatory body is expected by April 15, 2014. There is great concern revolving around this decision, as MannKind has already received two complete response letters (CRL) for Afrezza from the FDA, and it was requested to conduct two phase III trials with the next-generation inhaler. Further delay in approval or another setback related to this candidate could be a great danger for the company. Over and probably excessive dependence on Afrezza ���s the company discontinued any other reasearch in other candidates ���s something to worry about. The company has generated no revenue last year round and its shares have experienced a total annual loss of $0.64 so far.
- [By MONEYMORNING.COM]
Then there's Charles River Laboratories (NYSE: CRL). The company provides outsourcing for clinical research, allowing drug firms to keep their overhead down and pass the savings on to patients and their insurers.
Top 10 Healthcare Equipment Companies To Watch In Right Now: Rutter Inc (RUT)
Rutter Inc. (Rutter) focuses on providing technologies and manufacturing solutions. The Company supplies technologies to improve efficiency and safety in the marine, defense, transportation, oil and gas sectors. The Company produces and globally markets enhanced radar systems, including oil spill detection, ice navigator, small target detection and wave-monitoring systems. The Company also offers a full range of outsource manufacturing services including: product engineering and design; materials management; manufacturing; sub-assembly; systems integration; project management; testing; logistics and documentation and provides full cycle customer support for all Company products and selected third party components/products that it manufactures under contract. Rutter�� sigma S6 radar signal processing products are designed to enable end users to detect and track objects which would not be visible with conventional radar equipment only. Advisors' Opinion:- [By Anora Mahmudova]
The Russell 2000 (RUT) index of small stocks closed 11 points, or 1%, lower at 1,097.43.
- [By Wallace Witkowski]
Debate is still lively whether a bear market is lurking around the corner . Some argue that the meandering market is the grumbling of a bear market that will start with a whimper. Then, there�� also a historical precedence for weak markets before the midterm elections during a presidential cycle . And over the past few weeks, there�� a been a spike in worry that the selloff in small-cap stocks, reflected in the 10% pullback in the Russell 2000 (RUT) �, was the harbinger of a broader retreat.
- [By William L. Watts]
The first day of trading for Farmland (FPI) , which plans to get taxed as a real-estate investment trust, was hardly frothy. The stock ended at $12.98, down $1.02, or 7.3% below its $14 offering price. The broader market dropped sharply, sending the Russell 2000 (RUT) �down 1.4%, though some IPOs surged.
Top 10 Healthcare Equipment Companies To Watch In Right Now: PowerShares WilderHill Clean Energy Portfolio (PBW)
PowerShares WilderHill Clean Energy Portfolio (the Fund) is based on the WilderHill Clean Energy Index and seeks investment results that correspond generally to the price and yield (before the Fund�� fees and expenses) of that equity index. The sectors covered by the Fund include Energy-Alternate Sources, Semiconductors, Electrical Components and Equipment, Chemicals, Electric, Electronics, Computers, Auto Parts and Equipment, Biotechnology and Agriculture. PowerShares Capital Management LLC is the Fund's investment adviser.
PowerShares WilderHill Clean Energy Portfolio�� top 10 holdings include SunPower Corp., Class A, Echelon Corp., Cypress Semiconductor Corp., Cree, Inc., First Solar, Inc., OM Group, Inc., Universal Display Corp., KYOCERA Corp. ADR (Japan), Suntech Power Holdings Co., Ltd. ADR (Cayman Islands) and Applied Materials, Inc.
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some clean-energy-related stocks to your portfolio, the PowerShares WilderHill Clean Energy Portfolio ETF (NYSEMKT: PBW ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The PowerShares ETF's expense ratio -- its annual fee -- is 0.70%. The fund is fairly small, too, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in. - [By Wall Street Sector Selector]
Another ETF which invests in the solar sector is the PowerShares WilderHill Clean Energy ETF (PBW). Although its holdings are not limited to the solar sector, its most significant holding is SunPower Corporation at 4.96% of the weight. Its number three holding is MEMC Electronic Materials at 3.42% of the weight. PBW's average trading volume is robust at over 400,000 shares per day. Its market cap is $135 million.
- [By Aaron Levitt]
A lack of profits and the reliance on government subsidies have made most stocks in the renewable energy category pretty poor performers over the years. Just check out the performance of the broad PowerShares WilderHill Clean Energy ETF (PBW). It has lost about 7.5% annually since its inception in 2005.
No comments:
Post a Comment